Clinical trial

Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or Myeloma

NCT00276536

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2001-01-01

PhasePHASE1

Study timeline

Study start (unknown)2001-01-01Date precision: month

Registry last updated2015-10-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Kidney Cancerunresolved

Lymphomaunresolved

Melanomaunresolved

Multiple Myelomaunresolved

Sarcomaunresolved

Unspecified Adult Solid Tumor, Protocol Specificunresolved

Interventions

recombinant interferon alpha-1bBIOLOGICAL

IFNDRUG

Sponsors & collaborators

The Cleveland Cliniclead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

ClevelandOhio, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00276536 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.